779904 CPHXXX10.1177/1715163518779904C P J / R P CC P J / R P C research-article2018 CPhACONNECTION CPhA ConneCtion of cannabis, including participating in the Task CPhA’s position Force on Cannabis Legalization and Regulations As medication experts, pharmacists are best and appearing before the House of Commons equipped to provide clinical advice to patients Standing Committee on Health. Throughout and appropriate oversight in the safe manage- each consultation, we emphasized how pro- ment and dispensing of medical cannabis. Phar- posed legislation could ae ff ct patients relying on macists have the necessary expertise to help medical cannabis as part of their drug therapy manage potential risks associated with medi- regimen. CPhA also oer ff ed statements and com- cal cannabis, including adverse effects, harmful mentary throughout 2016 and 2017 as the federal drug interactions, contraindications and poten- government debated the proposed regulations. tial addictive behaviour. Pharmacists also have Education and practice tools: CPhA has the existing infrastructure in place to handle developed a number of resources to help phar- controlled substances, as well as a secure sup- macists provide effective medication manage- ply chain to limit diversion. CPhA believes that ment for their patients using medical cannabis, pharmacist management and dispensing of including the following: medical cannabis is the best option to strengthen any future framework, improve access and pro- • Online CE programs: “An Introduction to tect patient and public safety. With governments Medical Cannabis and Cannabinoids” and moving to pass regulations and prepare for legal- “Medical Cannabis: Applying the Evidence ization in 2018, CPhA has consistently stressed to Practice” are oer ff ed free of charge to the need to maintain a robust medical canna- members of provincial pharmacy associa- bis stream and improve patient care and safety tions and Association of Faculties of Phar- through pharmacist dispensing. macy of Canada (AFPC) • Medical Cannabis FAQ Overview of CPhA activities • Cannabis for Medical Purposes Evidence Independent research: In February 2016, CPhA Guide commissioned Abacus Data to survey Canadi- CPhA continues to work on this file and is ans on their perceptions and attitudes towards committed to working with governments to marijuana. In March 2016, CPhA commissioned mitigate risk and enhance safety for Canadians. KPMG research into the key benefits that could Additional education and practice tools will be be expected from pharmacist management and released throughout 2018 to support pharma- dispensing of medical cannabis. cists across Canada. For more information on Government submissions: Over the past 2 CPhA’s efforts on medical cannabis, please visit years, CPhA has been actively involved in the www.pharmacists.ca/cannabis. ■ government’s consultations on the legalization © The Author(s) 2018 DOI: 10.1177/1715163518779904 274 CPJ/RPC• July / August2018•VOL151,NO4
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada – SAGE
Published: Jul 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera